- Market cap
- $956.5M
Transcat Inc. (TRNS) is an Electrical Products company listed on NASDAQ. In the last 30 days Quantisnow tracked 12 wire items for TRNS, including 3 analyst ratings, 3 insider trades and 2 earnings updates. The most recent was published Nov 9, 2026.
TRNS rankings
Financial highlights
Full financials- Revenue, TTM
- $363.22M
- Revenue growth
- +20.0%
- Net income, TTM
- $4.59M
- Net margin
- 1.3%
- Free cash flow, TTM
- $22.97M
- Cash
- $5.76M
For the twelve months ended Sep 26, 2026, from SEC filings. Not investment advice.
News · 26 weeks47+400%
2026-05-242026-11-15
Mix2590d
- Insider12(48%)
- SEC Filings4(16%)
- Other3(12%)
- Analyst3(12%)
- Earnings2(8%)
- 13D/G1(4%)
Activity · 52 weeks6635 active days
Tap a day to see what happenedEarningsInsiderAnalystFilings and news
Latest news
25 items- INSIDERChief Human Resources Officer Conroy Theresa A. exercised 2,000 shares at a strike of $63.17 and covered exercise/tax liability with 1,550 shares, increasing direct ownership by 19% to 2,814 units (SEC Form 4)4 - TRANSCAT INC (0000099302) (Issuer)
- INSIDERSr. VP Finance & CFO Barbato Thomas L exercised 6,000 shares at a strike of $90.92 and covered exercise/tax liability with 5,488 shares, increasing direct ownership by 11% to 5,168 units (SEC Form 4)4 - TRANSCAT INC (0000099302) (Issuer)
- INSIDERPresident and CEO Irick Jaime A bought $230,366 worth of shares (2,275 units at $101.26) (SEC Form 4)4 - TRANSCAT INC (0000099302) (Issuer)
- 13D/GAmendment: SEC Form SCHEDULE 13G/A filed by Transcat Inc.SCHEDULE 13G/A - TRANSCAT INC (0000099302) (Subject)
- ANALYSTTranscat upgraded by Oppenheimer with a new price targetOppenheimer upgraded Transcat from Perform to Outperform and set a new price target of $115.00
- SECSEC Form 10-Q filed by Transcat Inc.10-Q - TRANSCAT INC (0000099302) (Filer)
- SECTranscat Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - TRANSCAT INC (0000099302) (Filer)
- PRTranscat Reports Strong Fiscal Second Quarter 2027 Financial Results with Double-Digit Service Organic Revenue* Growth and Significant Service Gross Margin ExpansionQ2’27 Service Revenue Increased 23% to $64.8 Million Q2'27 Service Gross Margin Expanded 220 Basis Points to 34% Q2’27 Distribution Revenue Grew 10% to $32.3 Million on Strong Demand for Rentals Q2'27 Total Revenue Increased 18% to $97.1 Million Management to Host Conference Call Today at 4:30 p.m. Eastern Time Transcat, Inc. (NASDAQ:TRNS) ("Transcat" or the "Company"), a leader in test, measurement, control and calibration, has reported its financial and operational results for its fiscal second quarter ended September 26, 2026 (the "second quarter") of fiscal year 2027. Management Commentary "Our fiscal second quarter results demonstrate strong execution across each pi
- PRTranscat to Attend Upcoming Investor Conferences in NovemberTranscat, Inc. (NASDAQ:TRNS) ("Transcat" or the "Company"), a leading provider of test measurement, control and calibration, today announced that management will attend the Baird 2026 Global Industrial Conference and 2026 Stephens Annual Investment Conference in November 2026.Transcat President and Chief Executive Officer Jaime Irick and Chief Financial Officer Tom Barbato will attend the Baird 2026 Global Industrial Conference and 2026 Stephens Annual Investment Conference in November 2026, where they are scheduled to host one-on-one meetings with institutional investors at each event. Mr. Irick and Mr. Barbato will also host an in-person presentation at the Baird 2026 Global Industrial Con
- ANALYSTCJS Securities initiated coverage on Transcat with a new price targetCJS Securities initiated coverage of Transcat with a rating of Market Outperform and set a new price target of $115.00
- ANALYSTTranscat upgraded by Northland Capital with a new price targetNorthland Capital upgraded Transcat from Market Perform to Outperform and set a new price target of $95.00
- PRTranscat to Host Second Quarter Fiscal Year 2027 Conference Call and Webcast on Tuesday, November 3, 2026 at 4:30 p.m. Eastern TimeTranscat, Inc. (NASDAQ:TRNS) ("Transcat" or the "Company"), a leading provider of accredited calibration services and test and measurement equipment, announced that it will release its results for the second quarter fiscal year 2027 ended September 26, 2026 after the close of financial markets on Tuesday, November 3, 2026. Transcat President and Chief Executive Officer Jaime Irick and Chief Financial Officer Thomas Barbato will host a conference call and webcast on Tuesday, November 3, 2026 at 4:30 p.m. ET to review the financial and operating results for the period and discuss its corporate strategy and outlook. A question-and-answer session will follow. Second Quarter Fiscal Year 2027
- INSIDERDirector Mecca Robert converted options into 1,587 shares, increasing direct ownership by 225% to 2,291 units (SEC Form 4)4 - TRANSCAT INC (0000099302) (Issuer)
- INSIDERDirector Langston Cynthia converted options into 1,587 shares, increasing direct ownership by 86% to 3,424 units (SEC Form 4)4 - TRANSCAT INC (0000099302) (Issuer)
- INSIDERDirector Kaniki Mbago M. converted options into 1,587 shares, increasing direct ownership by 61% to 4,180 units (SEC Form 4)4 - TRANSCAT INC (0000099302) (Issuer)
- INSIDERDirector Haseley Gary J. converted options into 1,587 shares, increasing direct ownership by 4% to 40,689 units (SEC Form 4)4 - TRANSCAT INC (0000099302) (Issuer)
- INSIDERDirector Gillette Christopher P. converted options into 1,587 shares, increasing direct ownership by 794% to 1,787 units (SEC Form 4)4 - TRANSCAT INC (0000099302) (Issuer)
- INSIDERDirector Deperrior Dawn converted options into 1,587 shares, increasing direct ownership by 225% to 2,291 units (SEC Form 4)4 - TRANSCAT INC (0000099302) (Issuer)
- INSIDERDirector Dominach Oksana S. converted options into 1,587 shares, increasing direct ownership by 37% to 5,933 units (SEC Form 4)4 - TRANSCAT INC (0000099302) (Issuer)
- INSIDERDirector Cairns Craig D. converted options into 1,587 shares, increasing direct ownership by 32% to 6,590 units (SEC Form 4)4 - TRANSCAT INC (0000099302) (Issuer)
- SECTranscat Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - TRANSCAT INC (0000099302) (Filer)
- SECSEC Form S-3ASR filed by Transcat Inc.S-3ASR - TRANSCAT INC (0000099302) (Filer)
- INSIDERDirector Dominach Oksana S. sold $625,876 worth of shares (7,312 units at $85.60), decreasing direct ownership by 63% to 4,346 units (SEC Form 4)4 - TRANSCAT INC (0000099302) (Issuer)
- PRTranscat Expands its Biomedical Calibration Channel with the Acquisition of Southeastern BiomedicalAcquisition Expands Accredited Biomedical Calibration Capabilities, Equipment Repair, and Preventative Maintenance Services and Strengthens Transcat's Presence with Hospital Networks and Healthcare Facilities Throughout the Southeastern United StatesSoutheastern Biomedical Owners will Remain with Transcat to Drive Growth of the Combined Biomedical BusinessTranscat, Inc. (NASDAQ:TRNS) ("Transcat" or the "Company"), a leading provider of accredited calibration services and test and measurement equipment, announced that it has acquired privately-held Southeastern Biomedical Associates Incorporated ("Southeastern") effective August 31, 2026.The $12.8 million purchase price was paid in cash and i
- PRTranscat to Participate in Jefferies, Lake Street and D.A. Davidson Investor Conferences in SeptemberTranscat, Inc. (NASDAQ:TRNS) ("Transcat" or the "Company"), a leading provider of test measurement, control and calibration, today announced that management will attend the 2026 Jefferies Global Industrials Conference, Lake Street Capital Markets 10th Annual Best Ideas Growth ("BIG10") Conference, and D.A. Davidson 25th Annual Diversified Industrials & Services Conference in September 2026. Transcat President and Chief Executive Officer Jaime Irick and Chief Financial Officer Thomas Barbato will attend the 2026 Jefferies Global Industrials Conference and the Lake Street Capital Markets 10th Annual Best Ideas Growth ("BIG10") Conference, where they are scheduled to host one-on-one meetings
TRNS FAQ
10 questionsWhat does Transcat Inc. do?
Transcat, Inc. provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates in two segments, Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services. This segment also provides CalTrak, a proprietary document and asset management software that is used to integrate and manage the workflow of its calibration service centers and customers' assets; and Compliance, Control and Cost, an online customer portal that provides...What is the latest news on TRNS?
In the last 30 days Quantisnow tracked 12 wire items for TRNS: 3 analyst ratings, 3 insider trades, 2 earnings updates and 2 SEC filings. The most recent was published on November 9, 2026.What is TRNS revenue?
Transcat Inc. (TRNS) reported $363.22M of revenue for the twelve months ended Sep 26, 2026. That is up 20.0% from the year before. Revenue for fiscal 2025 was $331.88M.Is TRNS profitable?
Yes. Transcat Inc. earned $4.59M in net income for the twelve months ended Sep 26, 2026, a net margin of 1.3%.How much cash and debt does TRNS have?
Transcat Inc. reported $5.76M in cash and cash equivalents and $116.89M of debt on its most recent balance sheet in SEC filings.Where does TRNS stock trade?
Transcat Inc. (TRNS) is listed on NASDAQ.What sector and industry is TRNS in?
Transcat Inc. operates in the Industrials sector, Electrical Products industry.What are analysts saying about TRNS?
Across the last 8 analyst actions on Transcat Inc., there were 2 upgrades and 3 downgrades. The most recent action was from Oppenheimer: Outperform with a $115.00 price target on 2026-11-04. Recent price targets range from $95.00 to $115.00.What companies are similar to TRNS?
Notable peers in the same industry include TER (Teradyne Inc.), LFUS (Littelfuse Inc.), FLEX (Flex Ltd.), APH (Amphenol Corporation), CLS (Celestica Inc.). Compare TRNS side-by-side with any of them on Quantisnow.How can I track TRNS on Quantisnow?
Quantisnow aggregates Transcat Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow TRNS to receive live email and push alerts on every new disclosure.